Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Nov;65(11):4384–4388. doi: 10.1128/iai.65.11.4384-4388.1997

Borrelia burgdorferi induces chemokines in human monocytes.

H Sprenger 1, A Krause 1, A Kaufmann 1, S Priem 1, D Fabian 1, G R Burmester 1, D Gemsa 1, M G Rittig 1
PMCID: PMC175630  PMID: 9353009

Abstract

Lyme disease is clinically and histologically characterized by strong inflammatory reactions that contrast the paucity of spirochetes at lesional sites, indicating that borreliae induce mechanisms that amplify the inflammatory response. To reveal the underlying mechanisms of chemoattraction and activation of responding leukocytes, we investigated the induction of chemokines in human monocytes exposed to Borrelia burgdorferi by a dose-response and kinetic analysis. Lipopolysaccharide (LPS) derived from Escherichia coli was used as a positive control stimulus. The release of the CXC chemokines interleukin-8 (IL-8) and GRO-alpha and the CC chemokines MIP-1alpha, MCP-1, and RANTES was determined by specific enzyme-linked immunosorbent assays, and the corresponding gene expression patterns were determined by Northern blot analysis. The results showed a rapid and strong borrelia-inducible gene expression which was followed by the release of chemokines with peak levels after 12 to 16 h. Spirochetes and LPS were comparably effective in stimulating IL-8, GRO-alpha, MCP-1, and RANTES expression, whereas MIP-1alpha production preceded and exceeded chemokine levels induced by LPS. Unlike other bacteria, the spirochetes themselves did not bear or release factors with intrinsic chemotactic activity for monocytes or neutrophils. Thus, B. burgdorferi appears to be a strong inducer of chemokines which may, by the attraction and activation of phagocytic leukocytes, significantly contribute to inflammation and tissue damage observed in Lyme disease.

Full Text

The Full Text of this article is available as a PDF (606.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baeuerle P. A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994;12:141–179. doi: 10.1146/annurev.iy.12.040194.001041. [DOI] [PubMed] [Google Scholar]
  2. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. Adv Immunol. 1994;55:97–179. [PubMed] [Google Scholar]
  3. Barbour A. G. Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev. 1988 Oct;1(4):399–414. doi: 10.1128/cmr.1.4.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barthold S. W., de Souza M. Exacerbation of Lyme arthritis in beige mice. J Infect Dis. 1995 Sep;172(3):778–784. doi: 10.1093/infdis/172.3.778. [DOI] [PubMed] [Google Scholar]
  5. Bender A., Amann U., Jäger R., Nain M., Gemsa D. Effect of granulocyte/macrophage colony-stimulating factor on human monocytes infected with influenza A virus. Enhancement of virus replication, cytokine release, and cytotoxicity. J Immunol. 1993 Nov 15;151(10):5416–5424. [PubMed] [Google Scholar]
  6. Beutler B., Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med. 1987 Feb 12;316(7):379–385. doi: 10.1056/NEJM198702123160705. [DOI] [PubMed] [Google Scholar]
  7. Burmester G. R. Lessons from Lyme arthritis. Clin Exp Rheumatol. 1993 Mar-Apr;11 (Suppl 8):S23–S27. [PubMed] [Google Scholar]
  8. Cerami A., Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today. 1988 Jan;9(1):28–31. doi: 10.1016/0167-5699(88)91353-9. [DOI] [PubMed] [Google Scholar]
  9. Colotta F., Borré A., Wang J. M., Tattanelli M., Maddalena F., Polentarutti N., Peri G., Mantovani A. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol. 1992 Feb 1;148(3):760–765. [PubMed] [Google Scholar]
  10. Duray P. H. Histopathology of clinical phases of human Lyme disease. Rheum Dis Clin North Am. 1989 Nov;15(4):691–710. [PubMed] [Google Scholar]
  11. Ebnet K., Simon M. M., Shaw S. Regulation of chemokine gene expression in human endothelial cells by proinflammatory cytokines and Borrelia burgdorferi. Ann N Y Acad Sci. 1996 Oct 25;797:107–117. doi: 10.1111/j.1749-6632.1996.tb52953.x. [DOI] [PubMed] [Google Scholar]
  12. Falk W., Goodwin R. H., Jr, Leonard E. J. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods. 1980;33(3):239–247. doi: 10.1016/0022-1759(80)90211-2. [DOI] [PubMed] [Google Scholar]
  13. Gong J. H., Sprenger H., Hinder F., Bender A., Schmidt A., Horch S., Nain M., Gemsa D. Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release. J Immunol. 1991 Nov 15;147(10):3507–3513. [PubMed] [Google Scholar]
  14. Graves D. T., Jiang Y. L., Williamson M. J., Valente A. J. Identification of monocyte chemotactic activity produced by malignant cells. Science. 1989 Sep 29;245(4925):1490–1493. doi: 10.1126/science.2781291. [DOI] [PubMed] [Google Scholar]
  15. Henke A., Mohr C., Sprenger H., Graebner C., Stelzner A., Nain M., Gemsa D. Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes. J Immunol. 1992 Apr 1;148(7):2270–2277. [PubMed] [Google Scholar]
  16. Häupl T., Hahn G., Rittig M., Krause A., Schoerner C., Schönherr U., Kalden J. R., Burmester G. R. Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis. Arthritis Rheum. 1993 Nov;36(11):1621–1626. doi: 10.1002/art.1780361118. [DOI] [PubMed] [Google Scholar]
  17. Imhof B. A., Dunon D. Leukocyte migration and adhesion. Adv Immunol. 1995;58:345–416. doi: 10.1016/s0065-2776(08)60623-9. [DOI] [PubMed] [Google Scholar]
  18. Kalish R. Lyme disease. Rheum Dis Clin North Am. 1993 May;19(2):399–426. [PubMed] [Google Scholar]
  19. Kelvin D. J., Michiel D. F., Johnston J. A., Lloyd A. R., Sprenger H., Oppenheim J. J., Wang J. M. Chemokines and serpentines: the molecular biology of chemokine receptors. J Leukoc Biol. 1993 Dec;54(6):604–612. doi: 10.1002/jlb.54.6.604. [DOI] [PubMed] [Google Scholar]
  20. Krause A., Brade V., Schoerner C., Solbach W., Kalden J. R., Burmester G. R. T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation. Arthritis Rheum. 1991 Apr;34(4):393–402. doi: 10.1002/art.1780340404. [DOI] [PubMed] [Google Scholar]
  21. Krause A., Burmester G. R., Rensing A., Schoerner C., Schaible U. E., Simon M. M., Herzer P., Kramer M. D., Wallich R. Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses. J Clin Invest. 1992 Sep;90(3):1077–1084. doi: 10.1172/JCI115923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Matsushima K., Morishita K., Yoshimura T., Lavu S., Kobayashi Y., Lew W., Appella E., Kung H. F., Leonard E. J., Oppenheim J. J. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med. 1988 Jun 1;167(6):1883–1893. doi: 10.1084/jem.167.6.1883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Murphy P. M. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol. 1994;12:593–633. doi: 10.1146/annurev.iy.12.040194.003113. [DOI] [PubMed] [Google Scholar]
  24. Nain M., Hinder F., Gong J. H., Schmidt A., Bender A., Sprenger H., Gemsa D. Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol. 1990 Sep 15;145(6):1921–1928. [PubMed] [Google Scholar]
  25. Nocton J. J., Steere A. C. Lyme disease. Adv Intern Med. 1995;40:69–117. [PubMed] [Google Scholar]
  26. Oppenheim J. J., Zachariae C. O., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol. 1991;9:617–648. doi: 10.1146/annurev.iy.09.040191.003153. [DOI] [PubMed] [Google Scholar]
  27. Qin S., LaRosa G., Campbell J. J., Smith-Heath H., Kassam N., Shi X., Zeng L., Buthcher E. C., Mackay C. R. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential. Eur J Immunol. 1996 Mar;26(3):640–647. doi: 10.1002/eji.1830260320. [DOI] [PubMed] [Google Scholar]
  28. Radolf J. D., Arndt L. L., Akins D. R., Curetty L. L., Levi M. E., Shen Y., Davis L. S., Norgard M. V. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol. 1995 Mar 15;154(6):2866–2877. [PubMed] [Google Scholar]
  29. Rittig M. G., Häupl T., Krause A., Kressel M., Groscurth P., Burmester G. R. Borrelia burgdorferi-induced ultrastructural alterations in human phagocytes: a clue to pathogenicity? J Pathol. 1994 Jul;173(3):269–282. doi: 10.1002/path.1711730311. [DOI] [PubMed] [Google Scholar]
  30. Rittig M. G., Krause A., Häupl T., Schaible U. E., Modolell M., Kramer M. D., Lütjen-Drecoll E., Simon M. M., Burmester G. R. Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi. Infect Immun. 1992 Oct;60(10):4205–4212. doi: 10.1128/iai.60.10.4205-4212.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Schaible U. E., Kramer M. D., Museteanu C., Zimmer G., Mossmann H., Simon M. M. The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis. J Exp Med. 1989 Oct 1;170(4):1427–1432. doi: 10.1084/jem.170.4.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schall T. J. Biology of the RANTES/SIS cytokine family. Cytokine. 1991 May;3(3):165–183. doi: 10.1016/1043-4666(91)90013-4. [DOI] [PubMed] [Google Scholar]
  33. Schröder J. M., Mrowietz U., Christophers E. Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity. J Immunol. 1988 May 15;140(10):3534–3540. [PubMed] [Google Scholar]
  34. Sigal L. H. Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu Rev Immunol. 1997;15:63–92. doi: 10.1146/annurev.immunol.15.1.63. [DOI] [PubMed] [Google Scholar]
  35. Sprenger H., Bacher M., Rischkowsky E., Bender A., Nain M., Gemsa D. Characterization of a high molecular weight tumor necrosis factor-alpha mRNA in influenza A virus-infected macrophages. J Immunol. 1994 Jan 1;152(1):280–289. [PubMed] [Google Scholar]
  36. Sprenger H., Konrad L., Rischkowsky E., Gemsa D. Background reduction in northern analysis by preabsorption of digoxigenin-labeled riboprobes. Biotechniques. 1995 Sep;19(3):334-6, 338-40. [PubMed] [Google Scholar]
  37. Sprenger H., Lloyd A. R., Lautens L. L., Bonner T. I., Kelvin D. J. Structure, genomic organization, and expression of the human interleukin-8 receptor B gene. J Biol Chem. 1994 Apr 15;269(15):11065–11072. [PubMed] [Google Scholar]
  38. Sprenger H., Lloyd A. R., Meyer R. G., Johnston J. A., Kelvin D. J. Genomic structure, characterization, and identification of the promoter of the human IL-8 receptor A gene. J Immunol. 1994 Sep 15;153(6):2524–2532. [PubMed] [Google Scholar]
  39. Sprenger H., Meyer R. G., Kaufmann A., Bussfeld D., Rischkowsky E., Gemsa D. Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection. J Exp Med. 1996 Sep 1;184(3):1191–1196. doi: 10.1084/jem.184.3.1191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sprenger H., Rösler A., Tonn P., Braune H. J., Huffmann G., Gemsa D. Chemokines in the cerebrospinal fluid of patients with meningitis. Clin Immunol Immunopathol. 1996 Aug;80(2):155–161. doi: 10.1006/clin.1996.0109. [DOI] [PubMed] [Google Scholar]
  41. Steere A. C., Duray P. H., Butcher E. C. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum. 1988 Apr;31(4):487–495. doi: 10.1002/art.1780310405. [DOI] [PubMed] [Google Scholar]
  42. Steere A. C. Lyme disease. N Engl J Med. 1989 Aug 31;321(9):586–596. doi: 10.1056/NEJM198908313210906. [DOI] [PubMed] [Google Scholar]
  43. Takayama K., Rothenberg R. J., Barbour A. G. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun. 1987 Sep;55(9):2311–2313. doi: 10.1128/iai.55.9.2311-2313.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Taub D. D., Anver M., Oppenheim J. J., Longo D. L., Murphy W. J. T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J Clin Invest. 1996 Apr 15;97(8):1931–1941. doi: 10.1172/JCI118625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wooten R. M., Modur V. R., McIntyre T. M., Weis J. J. Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-kappa B and inflammatory activation in human endothelial cells. J Immunol. 1996 Nov 15;157(10):4584–4590. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES